Endocannabinoid modulation of cortical up-states and NREM sleep

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Pava, Matthew J ^a   Den Hartog, Carolina R ^a   Blanco Centurion, Carlos ^b,c   Shiromani, Priyattam J ^b,c   Woodward, John J ^a,b  

^a MUSC Center for Drug and Alcohol Programs   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYL GLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLYCEROL; UNCLASSIFIED DRUG;

ACTION POTENTIAL; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CANNABINOID 1 RECEPTOR GENE; CONTROLLED STUDY; DOWN REGULATION; ELECTROENCEPHALOGRAM; GABAERGIC SYSTEM; GENE; GENE DELETION; MOLECULAR DYNAMICS; MOUSE; NEUROMODULATION; NONHUMAN; NONREM SLEEP; OSCILLATION; PREFRONTAL CORTEX; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION; SPIKE WAVE; SYNAPTIC TRANSMISSION; UPREGULATION; WAKEFULNESS;

ACTION POTENTIALS; ANIMALS; ARACHIDONIC ACIDS; BENZOXAZINES; CEREBRAL CORTEX; ENDOCANNABINOIDS; GAMMA-AMINOBUTYRIC ACID; GENE DELETION; GLUTAMATES; GLYCERIDES; INHIBITORY POSTSYNAPTIC POTENTIALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; NAPHTHALENES; NEOCORTEX; POLYUNSATURATED ALKAMIDES; PREFRONTAL CORTEX; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION; SLEEP, REM; SYNAPSES; TRPV CATION CHANNELS;

EID: 84895547400     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088672     Document Type: Article

References (70)

1. Amzica F, Steriade M (1998) Electrophysiological correlates of sleep delta waves. Electroencephalography and Clinical Neurophysiology 107: 69-83. (Pubitemid 28396638)
2. Steriade M, Nuñez A, Amzica F (1993) A novel slow (<1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci 13: 3252-3265. (Pubitemid 23241166)
3. Seamans JK, Nogueira L, Lavin A (2003) Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures. Cereb Cortex 13: 1242-1250. (Pubitemid 37323000)
4. Kroener S, Chandler LJ, Phillips PE, Seamans JK (2009) Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex. PLoS ONE 4: e6507.
5. Lambe EK, Aghajanian GK (2006) Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology 31: 1682-1689. (Pubitemid 44106699)
6. Lewis BL, O'Donnell P (2000) Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors. Cereb Cortex 10: 1168-1175.
7. Tu Y, Kroener S, Abernathy K, Lapish C, Seamans J, et al. (2007) Ethanol inhibits persistent activity in prefrontal cortical neurons. J Neurosci 27: 4765-4775. (Pubitemid 46663568)
8. Woodward JJ, Pava MJ (2009) Effects of ethanol on persistent activity and up-States in excitatory and inhibitory neurons in prefrontal cortex. Alcohol Clin Exp Res 33: 2134-2140.
9. Johnson HA, Buonomano DV (2007) Development and plasticity of spontaneous activity and Up states in cortical organotypic slices. J Neurosci 27: 5915-5925. (Pubitemid 46849757)
10. Woodward JJ, Pava M (2012) Ethanol inhibition of up-states in prefrontal cortical neurons expressing the genetically encoded calcium indicator GCaMP3. Alcohol Clin Exp Res 36: 780-787.
11. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592. (Pubitemid 32267203)
12. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380.
13. Atwood BK, Mackie K (2010) CB2: a cannabinoid receptor with an identity crisis. British Journal of Pharmacology 160: 467-479.
14. Fortin DA, Levine ES (2007) Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb Cortex 17: 163-174. (Pubitemid 44973905)
15. National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, National Academies Press (2011) Guide for the care and use of laboratory animals. Washington, D.C.: National Academies Press. xxv, 220 p. p.
16. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96: 5780-5785. (Pubitemid 29234695)
17. Shiromani PJ, Basheer R, Thakkar J, Wagner D, Greco MA, et al. (2000) Sleep and wakefulness in c-fos and fos B gene knockout mice. Brain Res Mol Brain Res 80: 75-87. (Pubitemid 30612439)
18. Huber R, Deboer T, Tobler I (2000) Effects of sleep deprivation on sleep and sleep EEG in three mouse strains: empirical data and simulations. Brain Res 857: 8-19. (Pubitemid 30107786)
19. Wang J, Ueda N (2009) Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat 89: 112-119.
20. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, et al. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87. (Pubitemid 26374593)
21. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, et al. (2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5: 37-44.
22. Sugiura T (2009) Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. BioFactors (Oxford, England) 35: 88-97.
23. Luk T, Jin W, Zvonok A, Lu D, Lin XZ, et al. (2004) Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist. British Journal of Pharmacology 142: 495-500. (Pubitemid 38869863)
24. Al-Hayani A, Wease KN, Ross RA, Pertwee RG, Davies SN (2001) The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41: 1000-1005. (Pubitemid 34024995)
25. Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA (2008) TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons. Neuron 57: 746-759. (Pubitemid 351335342)
26. Grueter BA, Brasnjo G, Malenka RC (2010) Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nature Neuroscience 13: 1519-1525.
27. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29: 717-727. (Pubitemid 32323944)
28. Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296: 678-682.
29. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29: 729-738. (Pubitemid 32323945)
30. Fortin DA, Trettel J, Levine ES (2004) Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92: 2105-2112. (Pubitemid 39298667)
31. Trettel J, Fortin DA, Levine ES (2004) Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (Lond) 556: 95-107. (Pubitemid 38515171)
32. Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431: 312-316. (Pubitemid 39265666)
33. Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, et al. (2003) Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 306: 363-370. (Pubitemid 36734393)
34. Durstewitz D, Seamans JK (2006) Beyond bistability: biophysics and temporal dynamics of working memory. Neuroscience 139: 119-133. (Pubitemid 44437550)
35. Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P, et al. (2007) Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE 2: e709.
36. Marrs WR, Blankman JL, Horne EA, Thomazeau A, Lin YH, et al. (2010) The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci 13: 951-957.
37. Marinelli S, Pacioni S, Bisogno T, Di Marzo V, Prince DA, et al. (2008) The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci 28: 13532-13541.
38. Galarreta M, Erdélyi F, Szabó G, Hestrin S (2004) Electrical coupling among irregular-spiking GABAergic interneurons expressing cannabinoid receptors. J Neurosci 24: 9770-9778. (Pubitemid 39463558)
39. Wedzony K, Chocyk A, Kolasiewicz W, Mackowiak M (2007) Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein. J Physiol Pharmacol 58: 611-624.
40. Bodor AL, Katona I, Nyíri G, Mackie K, Ledent C, et al. (2005) Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25: 6845-6856. (Pubitemid 41023152)
41. Kawaguchi Y (2001) Distinct firing patterns of neuronal subtypes in cortical synchronized activities. J Neurosci 21: 7261-7272.
42. Freund TF (2003) Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci 26: 489-495.
43. Trettel J, Levine ES (2002) Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J Neurophysiol 88: 534-539. (Pubitemid 34755374)
44. Trettel J, Levine ES (2003) Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. J Neurophysiol 89: 2334-2338. (Pubitemid 36444285)
45. Beltramo R, D'Urso G, Dal Maschio M, Farisello P, Bovetti S, et al. (2013) Layer-specific excitatory circuits differentially control recurrent network dynamics in the neocortex. Nat Neurosci 16: 227-234.
46. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457. (Pubitemid 29361798)
47. Tóth A, Boczán J, Kedei N, Lizanecz E, Bagi Z, et al. (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 135: 162-168. (Pubitemid 40602409)
48. Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular pharmacology 60: 155-163. (Pubitemid 32595243)
49. Roberto M, Cruz M, Bajo M, Siggins GR, Parsons LH, et al. (2010) The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 35: 1962-1972.
50. Ali AB, Todorova M (2010) Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1. Eur J Neurosci 31: 1196-1207.
51. Kim J, Alger BE (2010) Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nature Neuroscience 13: 592-600.
52. Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, et al. (2010) Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Eur J Neurosci 31: 1414-1422.
53. Mann EO, Kohl MM, Paulsen O (2009) Distinct roles of GABA(A) and GABA(B) receptors in balancing and terminating persistent cortical activity. J Neurosci 29: 7513-7518.
54. Sanchez-Vives MV, Mattia M, Compte A, Perez-Zabalza M, Winograd M, et al. (2010) Inhibitory modulation of cortical up states. J Neurophysiol 104: 1314-1324.
55. Mathur BN, Tanahira C, Tamamaki N, Lovinger DM (2013) Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity. Nat Neurosci 16: 1275-1283.
56. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88. (Pubitemid 37210691)
57. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, et al. (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51: 455-466. (Pubitemid 44209321)
58. Watson S, Chambers D, Hobbs C, Doherty P, Graham A (2008) The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation. Molecular and cellular neurosciences 38: 89-97.
59. Fujimori M, Himwich HE (1973) Delta 9-tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits. Physiol Behav 11: 291-295.
60. Moreton JE, Davis WM (1973) Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat. Neuropharmacology 12: 897-907.
61. Pivik RT, Zarcone V, Dement WC, Hollister LE (1972) Delta-9- tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther 13: 426-435.
62. Santucci V, Storme JJ, Soubrie P, Le Fur G (1996) Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life sciences 58: PL103-110. (Pubitemid 26037221)
63. Murillo-Rodríguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani PJ (2003) Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26: 943-947. (Pubitemid 39619752)
64. Murillo-Rodríguez E, Millán-Aldaco D, Di Marzo V, Drucker-Colin R (2008) The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. Neuroscience 157: 1-11.
65. Sales-Carbonell C, Rueda-Orozco PE, Soria-Gomez E, Buzsaki G, Marsicano G, et al. (2013) Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony. Proc Natl Acad Sci U S A 110: 719-724.
66. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, et al. (2007) Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316: 1212-1216. (Pubitemid 46880959)
67. Pava MJ, Woodward JJ (2012) A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol 46: 185-204.
68. Monti JM, Monti D (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 8: 133-148. (Pubitemid 38445488)
69. Ferretjans R, Moreira FA, Teixeira AL, Salgado JV (2012) The endocannabinoid system and its role in schizophrenia: a systematic review of the literature. Rev Bras Psiquiatr 34 Suppl 2: S163-177.
70. Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R, et al. (1998) Anandamide modulates sleep and memory in rats. Brain Res 812: 270-274. (Pubitemid 29005359)